MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 94 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $93,000 | -27.9% | 36,741 | -42.1% | 0.00% | -100.0% |
| Q1 2020 | $129,000 | -9.2% | 63,467 | -3.6% | 0.00% | 0.0% |
| Q4 2019 | $142,000 | -40.1% | 65,859 | -57.2% | 0.00% | -50.0% |
| Q3 2019 | $237,000 | -53.0% | 153,931 | +26.8% | 0.00% | -60.0% |
| Q2 2019 | $504,000 | -62.9% | 121,389 | -62.6% | 0.01% | -66.7% |
| Q1 2019 | $1,357,000 | +99.0% | 324,698 | +36.6% | 0.02% | +150.0% |
| Q4 2018 | $682,000 | -29.3% | 237,677 | +146.5% | 0.01% | -25.0% |
| Q3 2018 | $964,000 | +105.5% | 96,405 | -21.5% | 0.01% | +60.0% |
| Q1 2018 | $469,000 | +1102.6% | 122,744 | +2467.9% | 0.01% | – |
| Q4 2017 | $39,000 | – | 4,780 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |